Terazosin Capsule
Product Images NDC 27241-290

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Terazosin (NDC 27241-290). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10mg (Terazosin 10mg)

10mg (Terazosin 10mg)
This is a description of a medication containing terazosin hydrochloride in 10 mg capsules. The text specifies the usual dosage and storage conditions, including temperature range and protection from light and moisture. The medication is to be dispensed in a light-resistant and child-resistant container. It provides the contact information of the manufacturer, Ajanta Pharma USA Inc., with the product being made in India. The NDC number for the medication is also provided along with the quantity of 100 capsules.*
FDA Label Image

1mg (Terazosin 1mg)

1mg (Terazosin 1mg)
Each capsule contains terazosin hydrochloride, USP equivalent to 1 mg terazosin. The recommended dosage can be found in the package insert. Store between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). Protect from light and moisture. Dispense in a tight, light-resistant container with a child-resistant closure. Marketed by Ajanta Pharma USA Inc. Made in India. Contains 100 capsules. Product code: GUJ/DRUGS/G/25/2080.*
FDA Label Image

2mg (Terazosin 2mg)

2mg (Terazosin 2mg)
Each capsule contains terazosin hydrochloride, USP equivalent to 2 mg terazosin. The usual dosage and storage instructions are provided on the package. The medication should be kept at a temperature between 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). It is necessary to protect the medication from light and moisture and to dispense it in a light-resistant container with a child-resistant closure. This information is important to ensure the effectiveness and safety of the medication.*
FDA Label Image

5mg (Terazosin 5mg)

5mg (Terazosin 5mg)
Each capsule contains terazosin hydrochloride equivalent to 5 mg of terazosin. The usual dosage should be consulted in the package insert. It is recommended to store between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). Protect from light and moisture. Dispense in a tight light-resistant container with child-resistant closure. This product is child-resistant. Marketed by Ajanta Pharma USA Inc. Made in India. NDC 27241-290-01. Contains 100 Capsules.*
FDA Label Image

Figure1 (Terazosin Fig1)

FDA Label Image

Figure2 (Terazosin Fig2)

FDA Label Image

Figure3 (Terazosin Fig3)

Figure3 (Terazosin Fig3)
This appears to be a data set showing values at different time points and a mean change from baseline. The values possibly represent measurements or quantities recorded over a certain period, with the last row showing the mean change from the initial measurement. The data seems to be organized in a tabular format, although some characters are not readable due to errors.*
FDA Label Image

Structure (Terazosin Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.